Insider Transactions in Q3 2024 at Travere Therapeutics, Inc. (TVTX)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2024
|
Jeffrey A Meckler |
SELL
Open market or private sale
|
Direct |
40,000
-33.06%
|
$560,000
$14.06 P/Share
|
|
Sep 30
2024
|
Jeffrey A Meckler |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+24.84%
|
$400,000
$10.48 P/Share
|
|
Sep 10
2024
|
Jula Inrig CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
684
-1.09%
|
$8,208
$12.98 P/Share
|
|
Sep 09
2024
|
Christopher R. Cline CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,490
-3.23%
|
$27,390
$11.52 P/Share
|
|
Sep 09
2024
|
Peter Heerma CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,191
-1.99%
|
$24,101
$11.52 P/Share
|
|
Sep 09
2024
|
Jula Inrig CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,191
-3.38%
|
$24,101
$11.52 P/Share
|
|
Sep 09
2024
|
Eric M Dube CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
21,125
-5.51%
|
$232,375
$11.52 P/Share
|
|
Sep 09
2024
|
Elizabeth E Reed SVP, GC & CORPORATE SECRETARY |
SELL
Open market or private sale
|
Direct |
4,387
-5.28%
|
$48,257
$11.52 P/Share
|
|
Sep 09
2024
|
William E. Rote SENIOR VICE PRESIDENT, R&D |
SELL
Open market or private sale
|
Direct |
4,387
-4.94%
|
$48,257
$11.52 P/Share
|
|
Sep 05
2024
|
Christopher R. Cline CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
6,750
+8.05%
|
-
|
|
Sep 05
2024
|
Peter Heerma CHIEF COMMERCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
6,750
+5.77%
|
-
|
|
Sep 05
2024
|
Jula Inrig CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
6,750
+9.43%
|
-
|
|
Sep 05
2024
|
Eric M Dube CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
32,500
+7.82%
|
-
|
|
Sep 05
2024
|
Elizabeth E Reed SVP, GC & CORPORATE SECRETARY |
BUY
Grant, award, or other acquisition
|
Direct |
6,750
+7.52%
|
-
|
|
Sep 05
2024
|
William E. Rote SENIOR VICE PRESIDENT, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
6,750
+7.06%
|
-
|
|
Sep 04
2024
|
Christopher R. Cline CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
514
-0.73%
|
$4,626
$9.51 P/Share
|